Defence Therapeutics Inc. (DTCFF)

USD 0.62

(3.69%)

Long Term Debt Summary of Defence Therapeutics Inc.

  • Defence Therapeutics Inc.'s latest annual long term debt in 2024 was 7871.00 CAD , down -100.0% from previous year.
  • Defence Therapeutics Inc.'s latest quarterly long term debt in 2024 Q4 was 7871.00 CAD , down 0.0% from previous quarter.
  • Defence Therapeutics Inc. reported annual long term debt of 1.74 Million CAD in 2023, down 0.0% from previous year.
  • Defence Therapeutics Inc. reported annual long term debt of - CAD in 2022, down 0.0% from previous year.
  • Defence Therapeutics Inc. reported quarterly long term debt of 22.59 Thousand CAD for 2024 Q2, down -100.0% from previous quarter.
  • Defence Therapeutics Inc. reported quarterly long term debt of 1.63 Million CAD for 2024 Q1, down -6.19% from previous quarter.

Annual Long Term Debt Chart of Defence Therapeutics Inc. (2024 - 2019)

Historical Annual Long Term Debt of Defence Therapeutics Inc. (2024 - 2019)

Year Long Term Debt Long Term Debt Growth
2024 7871.00 CAD -100.0%
2023 1.74 Million CAD 0.0%
2022 - CAD 0.0%
2021 - CAD 0.0%
2020 - CAD 0.0%
2019 - CAD 0.0%

Peer Long Term Debt Comparison of Defence Therapeutics Inc.

Name Long Term Debt Long Term Debt Difference
ContraFect Corporation 2.21 Million USD 99.644%
Eiger BioPharmaceuticals, Inc. - USD -Infinity%
Nanobac Pharmaceuticals, Incorporated - USD -Infinity%
Institute of Biomedical Research Corp. - USD -Infinity%
SQZ Biotechnologies Company 20.9 Million USD 99.962%
Intellipharmaceutics International Inc. - USD -Infinity%
Evofem Biosciences, Inc. 8000.00 USD 1.613%
Santhera Pharmaceuticals Holding AG 1.75 Million USD 99.552%
Propanc Biopharma, Inc. 58.64 Thousand USD 86.578%
Marizyme, Inc. 667.12 Thousand USD 98.82%
Genus plc 228.2 Million USD 99.997%
Pharming Group N.V. 166.1 Million USD 99.995%
Therapeutic Solutions International, Inc. 5512.00 USD -42.798%
CNBX Pharmaceuticals Inc. - USD -Infinity%
Nymox Pharmaceutical Corporation - USD -Infinity%
RegeneRx Biopharmaceuticals, Inc. 1.4 Million USD 99.439%
IMV Inc. 27.39 Million USD 99.971%
AXIM Biotechnologies, Inc. 5.42 Million USD 99.855%
ONE Bio Corp. 592.19 Thousand USD 98.671%
RVL Pharmaceuticals plc 55.61 Million USD 99.986%
Neon Bloom, Inc. - USD -Infinity%
Mosaic ImmunoEngineering Inc. 1.22 Million USD 99.359%
Biomind Labs Inc. - USD -Infinity%
American Oriental Bioengineering, Inc. 554.59 Thousand USD 98.581%
Oncotelic Therapeutics, Inc. 1.89 Million USD 99.585%
Skye Bioscience, Inc. 171.23 Thousand USD 95.403%
GlobeStar Therapeutics Corporation - USD -Infinity%
Mesoblast Limited 100.29 Million USD 99.992%
THC Farmaceuticals, Inc. - USD -Infinity%
Arch Therapeutics, Inc. - USD -Infinity%
Acro Biomedical Co., Ltd. - USD -Infinity%
Curative Biotechnology, Inc. - USD -Infinity%
GB Sciences, Inc. 322 Thousand USD 97.556%
MultiCell Technologies, Inc. 36.43 USD -21505.819%
Alpha Cognition Inc. - USD -Infinity%
HST Global, Inc. - USD -Infinity%
CSL Limited 11.23 Billion USD 100.0%
Arno Therapeutics, Inc. - USD -Infinity%
Agentix Corp. - USD -Infinity%
Halberd Corporation 150 Thousand USD 94.753%
Enzolytics Inc. - USD -Infinity%
Resverlogix Corp. - USD -Infinity%
Nuo Therapeutics, Inc. 164.2 Thousand USD 95.207%
argenx SE 15.35 Million USD 99.949%
Enzon Pharmaceuticals, Inc. - USD -Infinity%
Emmaus Life Sciences, Inc. 2.22 Million USD 99.646%
Inhibitor Therapeutics, Inc. - USD -Infinity%
Bioxytran, Inc. - USD -Infinity%
Zenith Capital Corp. 4456.00 USD -76.638%
Anthera Pharmaceuticals, Inc. - USD -Infinity%
Sigyn Therapeutics, Inc. 126.3 Thousand USD 93.768%
WPD Pharmaceuticals Inc. 229.29 Thousand USD 96.567%
Cotinga Pharmaceuticals Inc. - USD -Infinity%
GlobeImmune, Inc. - USD -Infinity%
Adynxx, Inc. - USD -Infinity%
Genscript Biotech Corporation 287.12 Million USD 99.997%
Kadimastem Ltd 229.69 Thousand USD 96.573%
Helix BioMedix, Inc. - USD -Infinity%
VitaSpring Biomedical Co. Ltd. - USD -Infinity%
Provectus Biopharmaceuticals, Inc. 25.29 Thousand USD 68.888%
Capstone Therapeutics Corp. 8.26 Million USD 99.905%
VioQuest Pharmaceuticals, Inc. - USD -Infinity%
PsyBio Therapeutics Corp. - USD -Infinity%
Sienna Biopharmaceuticals, Inc. - USD -Infinity%
Oncology Pharma Inc. - USD -Infinity%
Accustem Sciences Inc. - USD -Infinity%
EV Biologics, Inc. - USD -Infinity%
Reve Technologies, Inc. 1064.00 USD -639.756%
Q BioMed Inc. - USD -Infinity%
LadRx Corporation - USD -Infinity%
Cell Source, Inc. - USD -Infinity%
TetraLogic Pharmaceuticals Corporation - USD -Infinity%
ProtoKinetix, Incorporated - USD -Infinity%
Regen BioPharma, Inc. 149.61 Thousand USD 94.739%
MetaStat, Inc. - USD -Infinity%
Northwest Biotherapeutics, Inc. 20.31 Million USD 99.961%
Itoco Inc. - USD -Infinity%
Rasna Therapeutics, Inc. - USD -Infinity%
Wesana Health Holdings Inc. - USD -Infinity%
Endonovo Therapeutics, Inc. - USD -Infinity%
Pathfinder Cell Therapy, Inc. - USD -Infinity%
RespireRx Pharmaceuticals Inc. - USD -Infinity%
GeneThera, Inc. - USD -Infinity%
AVAX Technologies, Inc. - USD -Infinity%
Ember Therapeutics, Inc. - USD -Infinity%
NovAccess Global Inc. - USD -Infinity%
Claritas Pharmaceuticals, Inc. - USD -Infinity%
NDT Pharmaceuticals Inc. - USD -Infinity%
BioStem Technologies, Inc. 265.63 Thousand USD 97.037%
NanoSphere Health Sciences Inc. - USD -Infinity%
Burzynski Research Institute, Inc. - USD -Infinity%
Qrons Inc. 80 Thousand USD 90.161%
Alseres Pharmaceuticals, Inc. 7.81 Million USD 99.899%
SYBLEU INC 300 Thousand USD 97.376%
Advanced Proteome Therapeutics Corporation - USD -Infinity%
Nascent Biotech, Inc. - USD -Infinity%
Rebus Holdings, Inc. - USD -Infinity%
Regen BioPharma, Inc. 149.61 Thousand USD 94.739%
ImmunoCellular Therapeutics, Ltd. 369.04 Thousand USD 97.867%
Affymax, Inc. - USD -Infinity%
Mobile Lads Corp. - USD -Infinity%
International Stem Cell Corporation 445 Thousand USD 98.231%
CytoDyn Inc. 141 Thousand USD 94.418%
Predictive Technology Group, Inc. - USD -Infinity%
ProText Mobility, Inc. - USD -Infinity%
Cardax, Inc. - USD -Infinity%
VG Life Sciences Inc. - USD -Infinity%
Kaleido Biosciences, Inc. - USD -Infinity%
Advaxis, Inc. 8.15 Million USD 99.903%
Adhera Therapeutics, Inc. - USD -Infinity%
RenovaCare, Inc. - USD -Infinity%
Regnum Corp. - USD -Infinity%
Innovation Pharmaceuticals Inc. 457 Thousand USD 98.278%
Neutra Corp. - USD -Infinity%
Windtree Therapeutics, Inc. 1.16 Million USD 99.322%
PureTech Health plc 18.25 Million USD 99.957%
Coeptis Therapeutics, Inc. 150 Thousand USD 94.753%
IXICO plc 275 Thousand USD 97.138%
IntelGenx Technologies Corp. 11.83 Million USD 99.934%
Gelesis Holdings, Inc. 26.3 Million USD 99.97%
CSL Limited 11.23 Billion USD 100.0%
Cellectis S.A. 36.21 Million USD 99.978%